Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• Hepatitis C virus (HCV) causes significant global morbidity, leading to chronic liver injury, cirrhosis, and cancer.
• While hepatocytes are known HCV reservoirs, non-parenchymal liver cells' roles are understudied.
• Liver sinusoidal endothelial cells (LSEC) are implicated in supporting HCV infection.

Purpose of the Study:

• To investigate the role of non-parenchymal cells, specifically LSEC, in the Hepatitis C virus lifecycle.
• To identify specific molecules secreted by LSEC that influence HCV replication.
• To elucidate the regulatory mechanisms controlling these molecules in the context of liver disease.

Main Methods:

• Transcript analysis to identify potential proviral factors secreted by LSEC.
• In vitro experiments using recombinant bone morphogenetic protein 4 (BMP4) to assess its effect on HCV replication.
• Neutralization assays to confirm BMP4's role in LSEC-conditioned media.
• Investigation of the signaling pathway involving vascular endothelial growth factor A (VEGF-A), VEGF receptor-2 (VEGFR-2), and p38 MAPK.

Main Results:

• Bone morphogenetic protein 4 (BMP4) was identified as an endothelial-expressed proviral molecule.
• Recombinant BMP4 enhanced HCV replication; BMP4 neutralization blocked LSEC-mediated proviral activity.
• VEGF-A negatively regulated BMP4 expression via VEGFR-2 and p38 MAPK signaling.
• In normal liver, VEGFR-2 is active and BMP4 is suppressed; in chronic liver disease (including HCV), VEGFR-2 is less active, and BMP4 is increased.

Conclusions:

• Liver sinusoidal endothelial cells (LSEC) and BMP4 play a significant role in Hepatitis C virus infection.
• BMP4 represents a novel therapeutic target for managing liver disease, particularly in the context of HCV infection.